High. This new approach, which adjusts the dose and duration of PARP inhibitor therapy based on individual patient response, has shown promising results in early clinical trials. By tailoring treatment...
Decline. This study investigates the impact of chemotherapy on the gut microbiome and its relationship to cognitive decline and inflammatory signals. Understanding this connection could lead to better management of...
This breakthrough will allow for more personalized and targeted treatments, ultimately leading to better outcomes for patients. The use of AI in this research sets it apart from traditional methods,...
Researchers uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating this disease. Researchers at Baylor College of...
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a new study....
Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, including Hodgkin...
Revolutionary Iontronic Technology: A Game-Changer in Cancer Treatment" The groundbreaking use of iontronic technology to administer low doses of cancer drugs near malignant brain tumors has shown remarkable results in...
, called arginine, to trigger a metabolic process that ultimately led to the death of cancer cells. This breakthrough offers a promising alternative to traditional cancer treatments, with the potential...
Of the ubiquitin ligase complex, which regulates protein degradation and plays a crucial role in cell growth and division. The study found that mutations in the KLHL6 gene led to...
Protected by structures called telomeres, which shorten as we age. Telo-seq revolutionizes the study of telomeres, providing unprecedented insights into their role in aging and disease. This cutting-edge tool promises...